Genetic Correlates in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Treated with Hyper-CVAD plus Dasatinib or Ponatinib

0
7
Scientists systematically analyzed genetic alterations in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia uniformly treated in clinical trials with dasatinib-based regimens or a ponatinib-based regimen.
[Leukemia]

Sorry, but the selected Zotpress account can't be found.

Abstract